Last reviewed · How we verify

NCT04438408: 2ndsouffle

National Survey on Care Pathway and Quality of Life in Patients With Severe Asthma According to Their Phenotype.

Status unknown Last updated 5 November 2020
What this trial tests

trial testing questionaires in Asthma Chronic in 400 participants. Status unknown.

Timeline
1 September 2020
Primary endpoint
1 September 2021
1 December 2021

Quick facts

Lead sponsorUniversity Hospital, Toulouse
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment400
Start date1 September 2020
Primary completion1 September 2021
Estimated completion1 December 2021
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Toulouse

Who can join

18 and older, any sex, with Asthma Chronic or Severe Asthma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The SECOND SOUFFLE survey focuses on aspects of care and quality of life in a period when the landscape of severe asthma is changing in the context of biotherapies. Moreover survey on care pathway and quality of life of the asthmatic severe population according to their phenotype have never been done. It is likely to bring results in a relatively fast time, results that can lead to guide the criteria collected in RAMSES a national severe asthma cohort and future research tracks of this cohort.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of questionaires

Trials testing the same drug.

Other recruiting trials for Asthma Chronic

Currently open trials in the same condition.

Other University Hospital, Toulouse trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04438408.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing